Advertisement

Organisation › Details
ICR Consilium (Consilium Strategic Communications Ltd.)
Consilium Strategic Communications is a global leader in strategic healthcare communications and investor relations advisory with offices in Europe and across the US. Consilium's highly skilled team provides strategic, long-term advice to healthcare companies, Boards, senior decision makers and executives on critical communications and IR programmes and stakeholder challenges. The Company has established deep knowledge across all areas of the global healthcare sector through broad experience in representing international clients spanning the Fortune 500, FTSE100, FTSEurofirst 300 and FTSE250, through to discrete specialist reputation management projects. *
![]() |
Start | 2023-09-12 renamed |
![]() |
End | 2024-10-22 renamed |
Group | ICR (Group) | |
Today | ICR Healthcare Europe (formerly ICR Consilium) | |
Predecessor | Consilium Strategic Communications Ltd. | |
Successor | ICR Healthcare Europe (formerly ICR Consilium) | |
![]() |
Industry | public relations / investor relations / marcom (services) |
Industry 2 | healthcare | |
![]() |
Person | Elliott, Mary-Jane (Consilium SC 201307– Managing Partner + Co-founder before M:Communications) |
Person 2 | Fennell, Amber (Bielecka, Amber) (Consilium Strategic Communications 201307– Co-founder) | |
![]() |
Region | London, Greater London |
Country | United Kingdom (GB) | |
Street | 85 Gresham Street | |
City | EC2V 7NQ London | |
Address record changed: 2024-12-18 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Consilium Strategic Communications Ltd.. (10/15/20). "Press Release: Consilium Strategic Communications Advises Compass Pathways on Its Successful Initial Public Offering". London. | ||
Record changed: 2024-12-18 |
Advertisement

More documents for ICR (Group)
- [1] Citryll B.V.. (12/9/24). "Press Release: Citryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disorders". Oss....
- [2] ICR Inc.. (10/22/24). "Press Release: ICR Healthcare Launches as a Unified Global Brand in Healthcare Strategic Communications and Investor Relations". New York, NY & London....
- [3] ICR Inc.. (9/12/23). "Press Release: ICR Acquires Consilium Strategic Communications, Creating Global Leader in Healthcare Communications and Investor Relations". New York, NY....
- [4] Consilium Strategic Communications Ltd.. (2/20/23). "Press Release: Consilium Strategic Communications Expands International Presence in US and Europe with Two Senior Strategic Advisor Appointments". London....
- [5] Alentis Therapeutics AG. (1/9/23). "Press Release: Positive Results from Single Ascending Dose Phase 1 Study of ALE.F02 Targeting Claudin-1". Basel....
- [6] Consilium Strategic Communications Ltd.. (5/6/22). "Press Release: Consilium Strategic Communications Appoints Tracy Cheung as Partner". London....
- [7] OMass Therapeutics Ltd.. (4/28/22). "Press Release: OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases". Oxford....
- [8] Glycotope GmbH. (3/24/22). "Press Release: Glycotope Announces New Strategy to Maximize Potential of Uniquely-Tumor Specific Antibody Platform". Berlin....
- [9] Emergex Vaccines Holding Ltd.. (11/18/20). "Press Release: Emergex Vaccines Raises US$11 Million to Advance Pipeline of Synthetic T-Cell Vaccines for Infectious Diseases". Abingdon....
- [10] Consilium Strategic Communications Ltd.. (11/10/20). "Press Release: Consilium Strategic Communications Strengthens Global Team in the US and Europe". London....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top